Ildefonso Espigado Tocino-rekin lankidetzan egindako argitalpenak (8)

2024

  1. Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients: final long-term analysis from a prospective multicenter Phase-II Trial

    Bone Marrow Transplantation

2002

  1. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors.

    Transfusion, Vol. 42, Núm. 1, pp. 4-9

  2. Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34+ cell yields

    Journal of Hematotherapy and Stem Cell Research, Vol. 11, Núm. 4, pp. 705-709

2001

  1. Allogeneic transplantation of CD34+ -selected cells from peripheral blood in patients with myeloid malignancies in early phase: A case control comparison with unmodified peripheral blood tranplantation

    Bone Marrow Transplantation, Vol. 28, Núm. 4, pp. 349-354

  2. Donor age-related differences in PBPC mobilization with rHuG-CSF

    Transfusion, Vol. 41, Núm. 2, pp. 201-205

  3. Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies

    British Journal of Haematology, Vol. 114, Núm. 3, pp. 544-550

1999

  1. Administration of recombinant human granulocyte colony-stimulating factor to normal donors: Results of the Spanish National Donor Registry

    Bone Marrow Transplantation, Vol. 24, Núm. 7, pp. 723-728

1997

  1. Trasplante alogénico de progenitores hemopoyéticos de sangre periférica no manipulados: Experiencia española de 79 casos

    Sangre, Vol. 42, Núm. SUPPL. 1, pp. 42-43